Related Experiment Video
Updated: Dec 30, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Development and evaluation of dapsone tablets coated for specific colon release
Priscila Debastiani Barros1, Isabela Fernanda Teixeira Dias1, Giovane Douglas Zanin2
1State University of Western Paraná, Cascavel, Brazil.
Drug release systems utilize biodegradable polysaccharides for colon-specific delivery. Dapsone tablets coated with Surelease® and chondroitin sulfate (SC) showed controlled release, with higher SC proportions enhancing drug delivery.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Materials Science
Background:
- Biodegradable polysaccharides are explored for colon-specific drug release systems.
- Modulating drug release into the colon is crucial for targeted therapy.
- Dapsone tablets were developed with a novel coating for colonic delivery.
Purpose of the Study:
- To develop and characterize dapsone tablets coated with Surelease® and chondroitin sulfate (SC) for modulated colonic release.
- To investigate the impact of coating composition and thickness on drug release kinetics.
- To optimize the formulation for targeted drug delivery to the colon.
Main Methods:
- Tablets were formulated using wet granulation and coated with varying Surelease® and SC proportions.
- Coated tablets underwent pharmacopeial assessments for weight, hardness, and friability.
- Dissolution testing was performed in simulated gastrointestinal fluids over 420 minutes, analyzed by factorial design.
Main Results:
- Coated tablets met pharmacopeial specifications for physical characteristics.
- Surelease® provided effective drug protection, with minimal release at 6-10% weight gain.
- Increased SC proportion (10%) and lower weight gain (6%) significantly enhanced dapsone release (9.5%).
Conclusions:
- Coating thickness and polysaccharide proportion are critical for controlling drug release.
- The developed system demonstrates potential for targeted colonic drug delivery.
- Optimized Surelease® and SC ratios can modulate dapsone release profiles.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Drug Dissolution: Requirements and Profile Comparison
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

